Genetics in MedicineGeneticsPeer-reviewed journal article
DYRK1A-related intellectual disability: a syndrome associated with congenital anomalies of the kidney and urinary tract
Alexandria T.M. BlackburniD, Nasim BekheirniaiD, Vanessa C. Uma, Mark E. CorkinsiD, Yuxiao XuiD, Jill Anne RosenfeldiD, Matthew N. BainbridgeiD, Yaping YangiD, Pengfei LiuiD, Suneeta Madan‐Khetarpal, Mauricio R. DelgadoiD, Louanne HudginsiD, Ian D. KrantziD, David Rodriguez‐BuriticaiD, Patricia G. WheeleriD, Lihadh Al‐GazaliiD, Aisha Mohamed Saeed Mohamed Al Shamsi, Natalia Gomez‐OspinaiD, Hsiao‐Tuan ChaoiD, Ghayda MirzaaiD, Angela E. ScheuerleiD, Mary K. KukolichiD, Fernando ScagliaiD, Christine M. EngiD, Helen Rankin WillseyiD, , Mir Reza BekheirniaiD
Abstract
PurposeHaploinsufficiency of DYRK1A causes a recognizable clinical syndrome. The goal of this paper is to investigate congenital anomalies of the kidney and urinary tract (CAKUT) and genital defects (GD) in patients with DYRK1A mutations.\n\nMethodsA large database of clinical exome sequencing (ES) was queried for de novo DYRK1A mutations and CAKUT/GD phenotypes were characterized. Xenopus laevis (frog) was chosen as a model organism to assess Dyrk1as role in renal development.\n\nResultsPhenotypic details and mutations of 19 patients were compiled after an initial observation that one patient with a de novo pathogenic mutation in DYRK1A had GD. CAKUT/GD data were available from 15 patients, 11 of whom present with CAKUT/GD. Studies in Xenopus embryos demonstrate that knockdown of Dyrk1a disrupts the development of segments of developing embryonic nephrons, which ultimately give rise to the entire genitourinary (GU) tract. These defects could be rescued by co-injecting wildtype human DYRK1A RNA, but not with truncated DYRK1AR205* RNA.\n\nConclusionEvidence supports routine GU screening of all individuals with de novo DYRK1A pathogenic variants to ensure optimized clinical management. Collectively, the reported clinical data and loss of function studies in Xenopus substantiate a novel role for DYRK1A in GU development.
- organism: mouse
- assay: whole-exome sequencing
- research focus: differential expression
- approach: experimental assay
- Citations
- 34
- FWCI
- 5.12
- Field percentile
- top 4%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Dyrk1a is required for craniofacial development in Xenopus laevis.
H. Katherine Johnson, Stacey Wahl, … AMANDA J.G. DICKINSON·Developmental BiologyPeer-reviewed·Apr 15, 2024
- Impaired development of neocortical circuits contributes to the neurological alterations in DYRK1A haploinsufficiency syndrome
Juan Arranz, Elisa Balducci, … Maria Lourdes Arbonés·Neurobiology of DiseasePeer-reviewed·Mar 1, 2019
- Integrative approach to interpret DYRK1A variants, leading to a frequent neurodevelopmental disorder
Jérémie Courraud, Eric Chater‐Diehl, … Amélie Piton·Genetics in MedicinePeer-reviewed·Aug 3, 2021
- Sex-specific developmental phenotypes and their response to neonatal Dyrk1a reduction in the Ts65Dn Down syndrome mouse model
Alyssa Duerst, Laura E. Hawley, … Randall J. Roper·bioRxiv·Jul 17, 2026
- Exome Reanalysis Identifies Novel Candidate Genes Associated with Congenital Anomalies of the Kidney and Urinary Tract in China
Huaping Sun, C N Wang, … Shaohua Fan·medRxiv·Feb 9, 2026
- Vascular defects of DYRK1A knockouts are ameliorated by modulating calcium signaling in zebrafish
Hyun-Ju Cho, Jae-Geun Lee, … Jeong-Soo Lee·Disease Models & MechanismsPeer-reviewed·May 1, 2019